Skip to main content
HeartCited

Nattokinase 用于 动脉粥样硬化

B 证据 至少一项随机试验支持这一结论，结果基本一致。

12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnattokinase\u0026condition\u003Datherosclerosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
结论

            
            
12-month RCT showed reduced carotid intima-media thickness progression. Fibrinolytic activity well-documented. Blood pressure reduction also demonstrated.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Review
                
                
                
                
            

            
                Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: None
                
                
                效果: None
                
                
                None
                
            

            
            
研究人群: Review of anti-atherosclerotic supplements and bleeding

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
4

        
研究数量

    

    

        
300

        
受试者

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
等级

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        International journal of …
                        2025
                        
                        1 次引用
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
常用剂量

                

                    
                    

                        
general:

                        
2,000 FU (fibrinolytic units)/day

                    

                    
                    

                        
cardiovascularsupport:

                        
2,000-4,000 FU/day

                    

                    
                

                
                

                    上限： Not formally established; up to 10,800 FU/day used in clinical trials
                

                
            

            

            
            

                
研究中使用的剂量

                

                    

                        
                            

                                剂量
                                持续时间
                                效果
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                最佳服用时间： On empty stomach (between meals) for optimal fibrinolytic activity
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
已报告的副作用

                    
    
                        
                        
  • 
                            ⚠
                            Generally well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            Increased bleeding risk (fibrinolytic activity)
                        
    • 
                        
                        
  • 
                            ⚠
                            Mild gastrointestinal discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            Bruising (rare)
                        
    • 
                        
                    

                

                

                
                

                    
已知相互作用

                    
    
                        
                        
  • 
                            ●
                            Anticoagulants — warfarin, DOACs (additive anticoagulant effects — contraindicated)
                        
    • 
                        
                        
  • 
                            ●
                            Antiplatelet drugs (additive bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            NSAIDs (increased bleeding risk)
                        
    • 
                        
                        
  • 
                            ●
                            Fish oil at high doses (additive anticoagulant effect)
                        
    • 
                        
                    

                

                

                
                

                    

                        可耐受最高摄入量： Not formally established; up to 10,800 FU/day used in clinical trials
                    

                

                
            

            

                在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Nattokinase help with 动脉粥样硬化?
            
        
        

            Based on 4 studies with 300 participants, there is moderate evidence from clinical studies that Nattokinase may support 动脉粥样硬化 management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Nattokinase should I take for 动脉粥样硬化?
            
        
        

            Studies have used various dosages. A commonly studied range is 2,000 FU (fibrinolytic units)/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Nattokinase?
            
        
        

            Reported side effects may include Generally well-tolerated, Increased bleeding risk (fibrinolytic activity), Mild gastrointestinal discomfort, Bruising (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Nattokinase and 动脉粥样硬化?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                
                

                
                

                    
Nattokinase 用于其他健康状况

                    

                        
                        
                            高血压
                            C

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Maria-Zinaida Dobre et al..
      Int J Mol Sci.
      2025.
      Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks.
      doi:10.3390/ijms262010183
      PubMed
    
    2. 
    
  















    

        FDA 免责声明:
        这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。